Abiopharma

News list

Denton Sheila A. 🟡 adjusted position in 598 shares (1 derivative) of INCYTE CORP (INCY) at $84.97 Transaction Date: Sep 02, 2025 | Filing ID: 000004

Full text

News bot Sept. 4, 2025, 8:05 p.m.
🔍 Denton Sheila A. (Executive)

Company: INCYTE CORP (INCY)

Report Date: 2025-09-02
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 598
- Total shares sold: 1,196
Detailed Transactions and Holdings:
- Acquired 598 shares of Common Stock at $58.06 per share (Direct)
  Date: 2025-09-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 33,798.00 | transaction_form_type: 4
- Sold 598 shares of Common Stock at $84.97 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 33,200.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 598 shares of Employee Stock Option (right to buy) at $58.06 per share (Derivative)
  Date: 2025-09-02 | Code: M | Expires: 2033-10-02 | equity_swap_involved: 0 | shares_owned_after: 14,962.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: This includes an aggregate of 32,544 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not vested.
- F2: Beginning October 2, 2023, options become exercisable in 37 installments, with the first 25% vesting on October 2, 2024 and the remainder vesting monthly over three years.